Copyright Reports & Markets. All rights reserved.

Global Interventional X-ray Contrast System Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Interventional X-ray Contrast System Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Interventional X-ray Contrast System by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Interventional X-ray Contrast System by Country/Region, 2017, 2022 & 2028
  • 2.2 Interventional X-ray Contrast System Segment by Type
    • 2.2.1 MRI System
    • 2.2.2 Ultrasound Imaging System
    • 2.2.3 CT Scanner
    • 2.2.4 Angiography System
    • 2.2.5 Fluoroscopy System
    • 2.2.6 Biopsy System
    • 2.2.7 Others
  • 2.3 Interventional X-ray Contrast System Sales by Type
    • 2.3.1 Global Interventional X-ray Contrast System Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Interventional X-ray Contrast System Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Interventional X-ray Contrast System Sale Price by Type (2017-2022)
  • 2.4 Interventional X-ray Contrast System Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Surgery Center
    • 2.4.3 Others
  • 2.5 Interventional X-ray Contrast System Sales by Application
    • 2.5.1 Global Interventional X-ray Contrast System Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Interventional X-ray Contrast System Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Interventional X-ray Contrast System Sale Price by Application (2017-2022)

3 Global Interventional X-ray Contrast System by Company

  • 3.1 Global Interventional X-ray Contrast System Breakdown Data by Company
    • 3.1.1 Global Interventional X-ray Contrast System Annual Sales by Company (2020-2022)
    • 3.1.2 Global Interventional X-ray Contrast System Sales Market Share by Company (2020-2022)
  • 3.2 Global Interventional X-ray Contrast System Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Interventional X-ray Contrast System Revenue by Company (2020-2022)
    • 3.2.2 Global Interventional X-ray Contrast System Revenue Market Share by Company (2020-2022)
  • 3.3 Global Interventional X-ray Contrast System Sale Price by Company
  • 3.4 Key Manufacturers Interventional X-ray Contrast System Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Interventional X-ray Contrast System Product Location Distribution
    • 3.4.2 Players Interventional X-ray Contrast System Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Interventional X-ray Contrast System by Geographic Region

  • 4.1 World Historic Interventional X-ray Contrast System Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Interventional X-ray Contrast System Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Interventional X-ray Contrast System Annual Revenue by Geographic Region
  • 4.2 World Historic Interventional X-ray Contrast System Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Interventional X-ray Contrast System Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Interventional X-ray Contrast System Annual Revenue by Country/Region
  • 4.3 Americas Interventional X-ray Contrast System Sales Growth
  • 4.4 APAC Interventional X-ray Contrast System Sales Growth
  • 4.5 Europe Interventional X-ray Contrast System Sales Growth
  • 4.6 Middle East & Africa Interventional X-ray Contrast System Sales Growth

5 Americas

  • 5.1 Americas Interventional X-ray Contrast System Sales by Country
    • 5.1.1 Americas Interventional X-ray Contrast System Sales by Country (2017-2022)
    • 5.1.2 Americas Interventional X-ray Contrast System Revenue by Country (2017-2022)
  • 5.2 Americas Interventional X-ray Contrast System Sales by Type
  • 5.3 Americas Interventional X-ray Contrast System Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Interventional X-ray Contrast System Sales by Region
    • 6.1.1 APAC Interventional X-ray Contrast System Sales by Region (2017-2022)
    • 6.1.2 APAC Interventional X-ray Contrast System Revenue by Region (2017-2022)
  • 6.2 APAC Interventional X-ray Contrast System Sales by Type
  • 6.3 APAC Interventional X-ray Contrast System Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Interventional X-ray Contrast System by Country
    • 7.1.1 Europe Interventional X-ray Contrast System Sales by Country (2017-2022)
    • 7.1.2 Europe Interventional X-ray Contrast System Revenue by Country (2017-2022)
  • 7.2 Europe Interventional X-ray Contrast System Sales by Type
  • 7.3 Europe Interventional X-ray Contrast System Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Interventional X-ray Contrast System by Country
    • 8.1.1 Middle East & Africa Interventional X-ray Contrast System Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Interventional X-ray Contrast System Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Interventional X-ray Contrast System Sales by Type
  • 8.3 Middle East & Africa Interventional X-ray Contrast System Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Interventional X-ray Contrast System
  • 10.3 Manufacturing Process Analysis of Interventional X-ray Contrast System
  • 10.4 Industry Chain Structure of Interventional X-ray Contrast System

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Interventional X-ray Contrast System Distributors
  • 11.3 Interventional X-ray Contrast System Customer

12 World Forecast Review for Interventional X-ray Contrast System by Geographic Region

  • 12.1 Global Interventional X-ray Contrast System Market Size Forecast by Region
    • 12.1.1 Global Interventional X-ray Contrast System Forecast by Region (2023-2028)
    • 12.1.2 Global Interventional X-ray Contrast System Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Interventional X-ray Contrast System Forecast by Type
  • 12.7 Global Interventional X-ray Contrast System Forecast by Application

13 Key Players Analysis

  • 13.1 Guerbet
    • 13.1.1 Guerbet Company Information
    • 13.1.2 Guerbet Interventional X-ray Contrast System Product Offered
    • 13.1.3 Guerbet Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Guerbet Main Business Overview
    • 13.1.5 Guerbet Latest Developments
  • 13.2 Smiths Medical
    • 13.2.1 Smiths Medical Company Information
    • 13.2.2 Smiths Medical Interventional X-ray Contrast System Product Offered
    • 13.2.3 Smiths Medical Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Smiths Medical Main Business Overview
    • 13.2.5 Smiths Medical Latest Developments
  • 13.3 ACIST Medical Systems
    • 13.3.1 ACIST Medical Systems Company Information
    • 13.3.2 ACIST Medical Systems Interventional X-ray Contrast System Product Offered
    • 13.3.3 ACIST Medical Systems Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 ACIST Medical Systems Main Business Overview
    • 13.3.5 ACIST Medical Systems Latest Developments
  • 13.4 Bracco
    • 13.4.1 Bracco Company Information
    • 13.4.2 Bracco Interventional X-ray Contrast System Product Offered
    • 13.4.3 Bracco Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Bracco Main Business Overview
    • 13.4.5 Bracco Latest Developments
  • 13.5 Kiran
    • 13.5.1 Kiran Company Information
    • 13.5.2 Kiran Interventional X-ray Contrast System Product Offered
    • 13.5.3 Kiran Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Kiran Main Business Overview
    • 13.5.5 Kiran Latest Developments
  • 13.6 Siemens Healthineers
    • 13.6.1 Siemens Healthineers Company Information
    • 13.6.2 Siemens Healthineers Interventional X-ray Contrast System Product Offered
    • 13.6.3 Siemens Healthineers Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Siemens Healthineers Main Business Overview
    • 13.6.5 Siemens Healthineers Latest Developments
  • 13.7 Fujifilm Holdings
    • 13.7.1 Fujifilm Holdings Company Information
    • 13.7.2 Fujifilm Holdings Interventional X-ray Contrast System Product Offered
    • 13.7.3 Fujifilm Holdings Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Fujifilm Holdings Main Business Overview
    • 13.7.5 Fujifilm Holdings Latest Developments
  • 13.8 GE Healthcare
    • 13.8.1 GE Healthcare Company Information
    • 13.8.2 GE Healthcare Interventional X-ray Contrast System Product Offered
    • 13.8.3 GE Healthcare Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 GE Healthcare Main Business Overview
    • 13.8.5 GE Healthcare Latest Developments
  • 13.9 Philips Healthcare
    • 13.9.1 Philips Healthcare Company Information
    • 13.9.2 Philips Healthcare Interventional X-ray Contrast System Product Offered
    • 13.9.3 Philips Healthcare Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Philips Healthcare Main Business Overview
    • 13.9.5 Philips Healthcare Latest Developments
  • 13.10 Shimadzu Corporation
    • 13.10.1 Shimadzu Corporation Company Information
    • 13.10.2 Shimadzu Corporation Interventional X-ray Contrast System Product Offered
    • 13.10.3 Shimadzu Corporation Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Shimadzu Corporation Main Business Overview
    • 13.10.5 Shimadzu Corporation Latest Developments
  • 13.11 Toshiba Medical Systems Corporation
    • 13.11.1 Toshiba Medical Systems Corporation Company Information
    • 13.11.2 Toshiba Medical Systems Corporation Interventional X-ray Contrast System Product Offered
    • 13.11.3 Toshiba Medical Systems Corporation Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Toshiba Medical Systems Corporation Main Business Overview
    • 13.11.5 Toshiba Medical Systems Corporation Latest Developments
  • 13.12 Carestream Health
    • 13.12.1 Carestream Health Company Information
    • 13.12.2 Carestream Health Interventional X-ray Contrast System Product Offered
    • 13.12.3 Carestream Health Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Carestream Health Main Business Overview
    • 13.12.5 Carestream Health Latest Developments
  • 13.13 Hitachi Medical Corporation
    • 13.13.1 Hitachi Medical Corporation Company Information
    • 13.13.2 Hitachi Medical Corporation Interventional X-ray Contrast System Product Offered
    • 13.13.3 Hitachi Medical Corporation Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Hitachi Medical Corporation Main Business Overview
    • 13.13.5 Hitachi Medical Corporation Latest Developments
  • 13.14 Hologic
    • 13.14.1 Hologic Company Information
    • 13.14.2 Hologic Interventional X-ray Contrast System Product Offered
    • 13.14.3 Hologic Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Hologic Main Business Overview
    • 13.14.5 Hologic Latest Developments
  • 13.15 Esaote
    • 13.15.1 Esaote Company Information
    • 13.15.2 Esaote Interventional X-ray Contrast System Product Offered
    • 13.15.3 Esaote Interventional X-ray Contrast System Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Esaote Main Business Overview
    • 13.15.5 Esaote Latest Developments

14 Research Findings and Conclusion

The global market for Interventional X-ray Contrast System is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Interventional X-ray Contrast System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Interventional X-ray Contrast System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Interventional X-ray Contrast System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Interventional X-ray Contrast System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Interventional X-ray Contrast System players cover Guerbet, Smiths Medical, ACIST Medical Systems, Bracco and Kiran, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Interventional X-ray Contrast System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Interventional X-ray Contrast System market, with both quantitative and qualitative data, to help readers understand how the Interventional X-ray Contrast System market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Interventional X-ray Contrast System market and forecasts the market size by Type (MRI System, Ultrasound Imaging System and CT Scanner), by Application (Hospital, Surgery Center and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others

Segmentation by application
Hospital
Surgery Center
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Guerbet
Smiths Medical
ACIST Medical Systems
Bracco
Kiran
Siemens Healthineers
Fujifilm Holdings
GE Healthcare
Philips Healthcare
Shimadzu Corporation
Toshiba Medical Systems Corporation
Carestream Health
Hitachi Medical Corporation
Hologic
Esaote

Chapter Introduction
Chapter 1: Scope of Interventional X-ray Contrast System, Research Methodology, etc.
Chapter 2: Executive Summary, global Interventional X-ray Contrast System market size (sales and revenue) and CAGR, Interventional X-ray Contrast System market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Interventional X-ray Contrast System sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Interventional X-ray Contrast System sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Interventional X-ray Contrast System market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Guerbet, Smiths Medical, ACIST Medical Systems, Bracco, Kiran, Siemens Healthineers, Fujifilm Holdings, GE Healthcare and Philips Healthcare, etc.
Chapter 14: Research Findings and Conclusion
Buy now